Coverage
-
March 24, 2023
Plaintiffs counsel in a class action from consumers who alleged Allergan and Merz delayed generic versions of Alzheimer's drugs from coming to market will be awarded 33.3%, plus litigation expense reimbursement, of an eight-figure settlement.
6 other articles on this case.
View all »